ID
45367
Descrição
Principal Investigator: Winnie S. Liang, PhD, Translational Genomics Research Institute, Phoenix, AZ, USA MeSH: Pancreatic Neoplasms,Carcinoma https://www.ncbi.nlm.nih.gov/projects/gap/cgi-bin/study.cgi?study_id=phs000550 In this study, we whole genome sequenced tumor/normal pairs from three pancreatic adenocarcinoma patients to separately characterize each patient with respect to somatic alterations. For 2 patients for whom tumor RNA was available, we also performed RNA sequencing to evaluate gene expression changes. While additional sequencing is needed to improve our understanding of the disease, the information acquired from this study contributes to our knowledge base on pancreatic cancer and helps to establish a foundation for identifying and developing more efficacious treatments for patients.
Link
Palavras-chave
Versões (1)
- 04/11/2022 04/11/2022 - Chiara Middel
Titular dos direitos
Winnie S. Liang, PhD, Translational Genomics Research Institute, Phoenix, AZ, USA
Transferido a
4 de novembro de 2022
DOI
Para um pedido faça login.
Licença
Creative Commons BY 4.0
Comentários do modelo :
Aqui pode comentar o modelo. Pode comentá-lo especificamente através dos balões de texto nos grupos de itens e itens.
Comentários do grupo de itens para :
Comentários do item para :
Para descarregar formulários, precisa de ter uma sessão iniciada. Por favor faça login ou registe-se gratuitamente.
dbGaP phs000550 Characterization of Pancreatic Adenocarcinoma Patients Using NGS
Eligibility Criteria
- StudyEvent: SEV1
- Eligibility Criteria
- Subject ID, type of research were used, and consent group of participants with pancreatic adenocarcinoma and involved in the "Genome-Wide Characterization of Pancreatic Adenocarcinoma Patients Using Next Generation Sequencing" project.
- Subject ID, sample ID, and sample use variable obtained from participants with pancreatic adenocarcinoma and involved in the "Genome-Wide Characterization of Pancreatic Adenocarcinoma Patients Using Next Generation Sequencing" project.
- Subject ID, age, sex, race, and current status of participants with pancreatic adenocarcinoma and involved in the "Genome-Wide Characterization of Pancreatic Adenocarcinoma Patients Using Next Generation Sequencing" project.
- Sample ID, body site where sample was collected, analyte type of samples, tumor status, primary tumor, metastasis, or transformed cell line, primary tumor location, tumor stage of samples, and type of tumor treatment for samples obtained from participants with pancreatic adenocarcinoma and involved in the "Genome-Wide Characterization of Pancreatic Adenocarcinoma Patients Using Next Generation Sequencing" project.
Similar models
Eligibility Criteria
- StudyEvent: SEV1
- Eligibility Criteria
- Subject ID, type of research were used, and consent group of participants with pancreatic adenocarcinoma and involved in the "Genome-Wide Characterization of Pancreatic Adenocarcinoma Patients Using Next Generation Sequencing" project.
- Subject ID, sample ID, and sample use variable obtained from participants with pancreatic adenocarcinoma and involved in the "Genome-Wide Characterization of Pancreatic Adenocarcinoma Patients Using Next Generation Sequencing" project.
- Subject ID, age, sex, race, and current status of participants with pancreatic adenocarcinoma and involved in the "Genome-Wide Characterization of Pancreatic Adenocarcinoma Patients Using Next Generation Sequencing" project.
- Sample ID, body site where sample was collected, analyte type of samples, tumor status, primary tumor, metastasis, or transformed cell line, primary tumor location, tumor stage of samples, and type of tumor treatment for samples obtained from participants with pancreatic adenocarcinoma and involved in the "Genome-Wide Characterization of Pancreatic Adenocarcinoma Patients Using Next Generation Sequencing" project.
C0001779 (UMLS CUI [1,2])
C0021430 (UMLS CUI [1,3])
C1521733 (UMLS CUI [2,1])
C0011900 (UMLS CUI [2,2])
C0346647 (UMLS CUI [2,3])
C0332140 (UMLS CUI [3,1])
C0346647 (UMLS CUI [3,2])
C3872529 (UMLS CUI [4,1])
C1301820 (UMLS CUI [4,2])
C0040300 (UMLS CUI [4,3])
C0030274 (UMLS CUI [4,4])
C3872529 (UMLS CUI [5,1])
C0728940 (UMLS CUI [5,2])
C0346647 (UMLS CUI [5,3])
C0205394 (UMLS CUI [6,1])
C1512693 (UMLS CUI [6,2])
C0206065 (UMLS CUI [6,3])
C0023671 (UMLS CUI [6,4])
C1442488 (UMLS CUI [6,5])
C0022877 (UMLS CUI [6,6])
C1511726 (UMLS CUI [6,7])
C1879533 (UMLS CUI [6,8])
C0005953 (UMLS CUI [6,9])
C0232741 (UMLS CUI [6,10])
C0232804 (UMLS CUI [6,11])